Kades & Cheifetz Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
|
+$1.95M |
| 2 |
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
|
+$1.24M |
| 3 |
Invesco Preferred ETF
PGX
|
+$1.08M |
| 4 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$847K |
| 5 |
Schwab 1-5 Year Corporate Bond ETF
SCHJ
|
+$613K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$1.53M |
| 2 |
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
|
+$868K |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$637K |
| 4 |
iShares Convertible Bond ETF
ICVT
|
+$485K |
| 5 |
Invesco Variable Rate Preferred ETF
VRP
|
+$439K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.8% |
| 2 | Industrials | 1.39% |
| 3 | Healthcare | 1.27% |
| 4 | Communication Services | 1.02% |
| 5 | Energy | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amgen
AMGN
$209B
| $233K | 0.17% |
809
-75
| -8% | -$20.4K |
|
77
Intuitive Surgical
ISRG
$127B
| $230K | 0.16% |
+681
| New | +$203K |
|
78
Vanguard ESG US Stock ETF
ESGV
$12.8B
| $226K | 0.16% |
+2,655
| New | +$209K |
|
79
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.79B
| $202K | 0.14% |
+5,322
| New | +$182K |
|
80
Arbutus Biopharma
ABUS
$847M
| $50K | 0.04% |
20,000
| – | – |
|
81
Costco
COST
$432B
| – | – |
-400
| Closed | -$226K |
|
|
SCHR
82
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| – | – |
-9,336
| Closed | -$224K |
|
|
BSCN
83
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| – | – |
-40,880
| Closed | -$868K |
|
Similar funds
Kades & Cheifetz's Q4 2023 Portfolio in Review
As of Q4 2023, Kades & Cheifetz held 83 positions worth $141M, up 12% from $126M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Kades & Cheifetz deployed $4.46M of net new capital in Q4 2023, opening 9 new positions and adding to 36 existing holdings. Its largest new stake was Vanguard Short-Term Tax-Exempt Bond ETF: 19,518 shares worth $1.98M.
By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 8.9% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, an estimated $1.53M trimmed.
- Kades & Cheifetz's largest Q4 2023 buy was Vanguard Short-Term Tax-Exempt Bond ETF: 19,518 shares worth $1.98M.
- Kades & Cheifetz added most to Strategy Shares Nasdaq 7HANDL Index ETF in Q4 2023, an estimated $1.24M increase.
- Kades & Cheifetz's biggest Q4 2023 reduction was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, cutting an estimated $1.53M.
- Kades & Cheifetz fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $868K.
- Kades & Cheifetz's ten largest holdings make up 49% of its $141M portfolio in Q4 2023.
- Kades & Cheifetz opened 9 new positions and closed 3 in Q4 2023.
- Kades & Cheifetz's portfolio value rose 12% quarter-over-quarter to $141M.
Based on Kades & Cheifetz's 13F filing for Q4 2023, filed 30 Jan 2024.